|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C07K 14/54 | (2006.01) | ||
| C07K 14/535 | (2006.01) |
| (11) | Number of the document | 3556206 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19176252.5 |
| Date of filing the European patent application | 2013-11-05 | |
| (97) | Date of publication of the European application | 2019-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261722437 P | 2012-11-05 | US |
| (72) |
FLAVELL, Richard , US
STROWIG, Till , DE
MANZ, Markus G. , CH
BORSOTTI, Chiara , US
DHODAPKAR, Madhav , US
MURPHY, Andrew J. , US
STEVENS, Sean , US
YANCOPOULOS, George D. , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
Yale University , Two Whitney Avenue, New Haven, CT 06510, US Institute for Research in Biomedicine (IRB) , Via Vincenzo Vela 6, 6501 Bellinzona, CH |
| (54) | GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF |
| GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF |